Fig. 3From: Comparison of surgery rates in biologic-naïve patients with Crohn’s disease treated with vedolizumab or ustekinumab: findings from SOJOURNKaplan–Meier curve for time to first Crohn’s disease-related surgery on biologic treatmentBack to article page